Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

EntreMed reports positive preclinical results using Endostatin

Dec. 3, 1997

ALVAC-IL-12 gene therapy effective in murine model of breast cancer

Dec. 2, 1997

Heterocyclic antitumor agents from Dainippon

Dec. 2, 1997

Steroidal anticancer compounds isolated from C. africana

Dec. 2, 1997

Angiostatin production mechanism elucidated; may permit large-scale studies

Dec. 2, 1997

U.S. patent covers new melanoma antigen/MAb discovered by Cytoclonal

Dec. 1, 1997

Phase I/II clinical trial of gene therapy for melanoma

Dec. 1, 1997

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

BE-32030B: new antitumor agent produced by Nocardia

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...